Effects of Hypericum perforatum on Levels of 5-Hydroxytryptamine, Noradrenaline and Dopamine in the Cortex, Diencephalon and Brainstem of the Rat
- 1 June 1999
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 51 (6) , 723-728
- https://doi.org/10.1211/0022357991772862
Abstract
The plant Hypericum perforatum is used in folk medicine to treat several diseases and research attention has been recently focused on its antidepressant action. Hypericin and flavonoids are the most important constituents of the plant, but the exact role of these compounds in the effects of hypericum on mood disorders is not well known. We have investigated the contribution of these compounds to the antidepressant effects of hypericum. The effects of acute administration of hypericum extracts on levels of 5-hydroxytryptamine (5-HT), tryptophan, 5-hydroxyindoleacetic acid (5-HIAA), noradrenaline and dopamine in the cortex, diencephalon and brainstem was evaluated. The levels of these neurotransmitters were measured 1 h and 24 h after administration of two different extracts, one containing 0.3% hypericin and 6% flavonoids (Li 160; 25–500 mg kg−1), the other containing 0.3% hypericin and 50% flavonoids (Ph-50; 25–500 mg kg−1). Results from experiments performed on 5-HT turnover were compared with the effects of fluoxetine (10–80 mg kg−1). Li 160, Ph-50 and fluoxetine induced a significant increase in the 5-HT content of the cortex. In the diencephalon Ph-50, but not Li 160 or fluoxetine, elicited an increase in 5-HT and 5-HIAA levels. In the brainstem Ph-50 and fluoxetine caused an increase in 5-HT content; Li 160 did not change neurotransmitter content. Both Li 160 and Ph-50 caused increases of noradrenaline and dopamine in the diencephalon. In the brainstem only Ph-50 induced an increase in noradrenaline content. Our data confirm that acute administration of hypericum extracts modifies the levels of neurotransmitters involved in the pathophysiology of mood disorders. When the extracts contain a higher concentration of flavonoids the effects are more widespread and involve brain regions such as diencephalon and brainstem that are implicated in depression.Keywords
This publication has 27 references indexed in Scilit:
- Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in HumansPharmacopsychiatry, 1997
- Biologically Active and Other Chemical Constituents of the Herb ofHypericum perforatumL.Pharmacopsychiatry, 1997
- Is there a role for a pure noradrenergic drug in the treatment of depression?European Neuropsychopharmacology, 1997
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Inhibition of MAO by Fractions and Constituents of Hypericum ExtractJournal of Geriatric Psychiatry and Neurology, 1994
- Instructions for AuthorsJournal of Geriatric Psychiatry and Neurology, 1994
- Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nucleiSynapse, 1993
- A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and ?-endorphin in melancholic patientsActa Psychiatrica Scandinavica, 1991
- Use of in situ hybridization to investigate the regulation of hippocampal corticosteroid receptors by monoaminesThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Inhibition of Monoamine Oxidase by HypercinPlanta Medica, 1984